CetuGEX showed improved anti-tumor activities, reduced side effects and a broader patient and indication range. The 1:1 randomized Phase IIb trial is designed to assess the efficacy and
Under the deal, Evotec will be responsible for discovery and pre-clinical development efforts, while Debiopharm will manage clinical development. The deal will see Evotec receive R&D funding and
Currently, Azedra is in Phase II registrational trial in patients suffering from pheochromocytoma and paraganglioma. Progenics CEO Mark Baker said CPDC, and their host, McMaster University, serve as
SMA is an autosomal-recessive genetic disorder characterized by progressive weakness of the lower motor neurons. It is caused by a genetic defect in the SMN1 gene, which codes
Taclonex Ointment is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 18 years and older. According to Symphony Health Solutions, brand
The acquisition elevates Actavis into a top-five position in the Thai generic pharmaceutical market, with leading positions in the ophthalmic and respiratory therapeutic categories and a strong cardiovascular
The approval is based on the data from an open label, multi-center Phase IV trial designed to evaluate the safety and immunogenicity of a single dose of Adacel
The research collaboration will be jointly funded by EMD Serono and Pfizer. SLE is a systemic autoimmune disease that can lead to LN, a kidney disorder that is
The injection is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Adenosine features the company’s PreventIV Measures packaging and labeling, designed
Additionally, Eisai has assigned the patent right for its metabolic enzyme inhibitor E7727 to Otsuka. As part of the deal, Eisai will transfer to Otsuka its rights to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.